Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 3Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1

Interventions

Specimen Handling 190Magnetic Resonance Spectroscopy 141Biopsy 101pembrolizumab 82Carboplatin 77Cisplatin 69Nivolumab 61Radiotherapy 50Paclitaxel 50Gemcitabine 50Dexamethasone 45Cyclophosphamide 45atezolizumab 38Radiation 38Pemetrexed 38durvalumab 36venetoclax 32Etoposide 32Bevacizumab 32olaparib 31Lenalidomide 31X-Rays 30Rituximab 30Docetaxel 30Doxorubicin 29Disulfides 28Prednisone 27Immunoglobulin G 27Vincristine 26Ipilimumab 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Liposomes × 30 days × Clear all
NCT04195945 2026-05-14

CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients

Fred Hutchinson Cancer Center

Phase 2 Active not recruiting
60 enrolled 19 charts
Other hematologic neoplasm

Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡